Broker UBS has just upgraded its share price target for Telix Pharmaceuticals Ltd after the company announced some positive news this week.
Health / United States
UBS thinks Telix Pharmaceuticals shares will go how high?
From the report
Headline check
The one thing this headline claims is in the report.
Figures, names and quoted words in the headline, looked for in the report itself — not in the summary above. One claim in this headline could be checked, so this is a narrow pass and not a thorough one. How this is checked
A summary of The Motley Fool Australia’s report. The score is for the full 426-word report.
How calmly it was written
Only this newsroom has covered it so far.
| Outlet | Niral Score |
|---|---|
| The Motley Fool Australiaas they published this story | 87.5 |
How did this read?
Sign in to react.
Comments
Comments are not open yet. They will be once there is someone to read every one before it appears. If something here is wrong, tell us — that we do read.
Report a problem with these scores or this rewrite — it goes straight into the public ledger.